Caroline F. van Hove
Chairman chez SIENTRA, INC.
Fortune : 1 936 $ au 31/03/2024
Profil
Caroline F.
van Hove is currently the President, Chief Executive Officer & Director at Revelle Aesthetics, Inc. She is also the Executive Chairman at Sientra, Inc. and the Director at The Plasticos Foundation.
Previously, she worked at Allergan, Inc. as the Head-Global Corporate Communications from 2002 to 2011.
She then served as the Chief Commercial Officer at Sienna Biopharmaceuticals, Inc. from 2018 to 2019.
Ms. van Hove completed her undergraduate studies at the University of Central Florida and the University of Antwerp.
She also holds an MBA from the Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SIENTRA, INC.
0,07% | 13/11/2023 | 8 239 ( 0,07% ) | 1 936 $ | 31/03/2024 |
Postes actifs de Caroline F. van Hove
| Sociétés | Poste | Début |
|---|---|---|
| SIENTRA, INC. | Chairman | 09/11/2020 |
| The Plasticos Foundation | Director/Board Member | - |
Revelle Aesthetics, Inc.
 Revelle Aesthetics, Inc. Medical SpecialtiesHealth Technology Revelle Aesthetics, Inc. is a privately held medtech company based in Mountain View, CA. Bright, and Jonathan Podmore. Revelle Aesthetics is committed to developing precision technologies that deliver meaningful results for women and reliable outcomes for physicians. The company's first device, avéli®, is FDA-cleared and TGA authorized for long-term reduction in the appearance of cellulite in the buttock and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation. The company was founded in 2018 by Joshua Makower, Earl A. The CEO is Caroline F. van Hove. | Chief Executive Officer | - |
Anciens postes connus de Caroline F. van Hove
| Sociétés | Poste | Fin |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 |
| ALLERGAN, INC. | Public Communications Contact | - |
Formation de Caroline F. van Hove
| University of Central Florida | Undergraduate Degree |
| University of Antwerp | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SIENTRA, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| The Plasticos Foundation | |
Revelle Aesthetics, Inc.
Revelle Aesthetics, Inc. Medical SpecialtiesHealth Technology Revelle Aesthetics, Inc. is a privately held medtech company based in Mountain View, CA. Bright, and Jonathan Podmore. Revelle Aesthetics is committed to developing precision technologies that deliver meaningful results for women and reliable outcomes for physicians. The company's first device, avéli®, is FDA-cleared and TGA authorized for long-term reduction in the appearance of cellulite in the buttock and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation. The company was founded in 2018 by Joshua Makower, Earl A. The CEO is Caroline F. van Hove. | Health Technology |
